Characterization of CD8+ T cell function and immunodominance generated with an H2O2-inactivated whole-virus vaccie

Journal of Virology

Volumn 86, Issue 24, 2012, Pages 13735-13744

  Walker, Joshua M ^a   Raué, Hans Peter ^a   Slifka, Mark K ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN; HYDROGEN PEROXIDE LYMPHOCYSTIC CHRIOMENINGITIS VIRUS VACCINE; INTERLEUKIN 2; NUCLEOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; TREATMENT RESPONSE; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; HYDROGEN PEROXIDE; IMMUNODOMINANT EPITOPES; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MICE; MICE, INBRED C57BL; MICE, SCID; MOLECULAR SEQUENCE DATA; VIRAL VACCINES;

ANIMALIA; LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

EID: 84870786620     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02178-12     Document Type: Article

References (64)

1. Ahmed R, Butler LD, Bhatti L. 1988. T4+ T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J. Virol. 62:2102-2106.
2. Ahmed R, Salmi A, Butler LD, Chiller JM, Oldstone MB. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160:521-540.
3. Amanna IJ, Messaoudi I, Slifka MK. 2008. Protective immunity following vaccination: how is it defined? Hum. Vaccin. 4:316 -319.
4. Amanna IJ, Raue HP, Slifka MK. 2012. Development of a new hydrogen peroxide-based vaccine platform. Nat. Med. 18:974 -979.
5. Annunziato D, et al. 1982. Atypical measles syndrome: pathologic and serologic findings. Pediatrics 70:203-209.
6. Barelli S, et al. 2008. Oxidation of proteins: basic principles and perspectives for blood proteomics. Proteomics Clin. Appl. 2:142-157.
7. Belz GT, Xie W, Doherty PC. 2001. Diversity of epitope and cytokine profiles for primary and secondary influenza A virus-specific CD8+T cell responses. J. Immunol. 166:4627-4633.
8. Betts MR, et al. 2006. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107:4781- 4789.
9. Brown F. 1993. Review of accidents caused by incomplete inactivation of viruses. Dev. Biol. Stand. 81:103-107.
10. Buchmeier MJ, de la Torre JC, Peters CJ. 2007. Arenaviridae: the viruses and their replication. In Knipe DM, et al (ed), Fields virology, 5th ed., p 1792-1827. Lippincott Williams & Wilkins, Philadelphia, PA.
11. Buchmeier MJ, Welsh RM, Dutko FJ, Oldstone MB. 1980. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 30:275-331.
12. Butz EA, Bevan MJ. 1998. Differential presentation of the same MHC class I epitopes by fibroblasts and dendritic cells. J. Immunol. 160:2139-2144.
13. Delgado MF, et al. 2009. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat. Med. 15:34-41.
14. Dow C, et al. 2008. Lymphocytic choriomeningitis virus infection yields overlapping CD4+ and CD8+ T-cell responses. J. Virol. 82:11734-11741.
15. Feau S, Arens R, Togher S, Schoenberger SP. 2011. Autocrine IL-2 is required for secondary population expansion of CD8(+) memory T cells. Nat. Immunol. 12:908 -913.
16. Finnegan M, et al. 2010. Mode of action of hydrogen peroxide and other oxidizing agents: differences between liquid and gas forms. J. Antimicrob. Chemother. 65:2108 -2115.
17. Fung-Leung WP, Kundig TM, Zinkernagel RM, Mak TW. 1991. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression. J. Exp. Med. 174:1425-1429.
18. Gairin JE, Mazarguil H, Hudrisier D, Oldstone MB. 1995. Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes. J. Virol. 69:2297-2305.
19. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:621- 667.
20. Harty JT, Tvinnereim AR, White DW. 2000. CD8+ T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol. 18:275-308.
21. Hombach J, Pircher H, Tonegawa S, Zinkernagel RM. 1995. Strictly transporter of antigen presentation (TAP)-dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal sequence of a virus protein. J. Exp. Med. 182:1615-1619.
22. Kaech SM, Wherry EJ, Ahmed R. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2:251-262.
23. Kastenmüller K, et al. 2011. Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets. J. Clin. Invest. 121:1782-1796.
24. Kastenmuller W, et al. 2007. Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination. J. Exp. Med. 204:2187-2198.
25. Kim HW, et al. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:422- 434.
26. Kotturi MF, et al. 2007. The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus. J. Virol. 81:4928-4940.
27. Kotturi MF, et al. 2008. Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance. J. Immunol. 181:2124 -2133.
28. La Gruta NL, et al. 2006. A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies. Proc. Natl. Acad. Sci. U. S. A. 103:994 -999.
29. Lanier JG, Newman MJ, Lee EM, Sette A, Ahmed R. 1999. Peptide vaccination using nonionic block copolymers induces protective antiviralCTL responses. Vaccine 18:549 -557.
30. Liu F, Whitton JL, Slifka MK. 2004. The rapidity with which virusspecific CD8+ T cells initiate IFN-gamma synthesis increases markedly over the course of infection and correlates with immunodominance. J. Immunol. 173:456-462.
31. Matloubian M, Concepcion RJ, Ahmed R. 1994. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:8056-8063.
32. Moskophidis D, Cobbold SP, Waldmann H, Lehmann-Grube F. 1987. Mechanism of recovery from acute virus infection: treatment of lymphocytic choriomeningitis virus-infected mice with monoclonal antibodies reveals that Lyt-2+T lymphocytes mediate clearance of virus and regulate the antiviral antibody response. J. Virol. 61:1867-1874.
33. Murali-Krishna K, et al. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177-187.
34. Oldstone MB, et al. 1985. Virus and immune responses: lymphocytic choriomeningitis virus as a prototype model of viral pathogenesis. Br. Med. Bull. 41:70 -74.
35. Oldstone MB, et al. 1993. Vaccination to prevent persistent viral infection. J. Virol. 67:4372- 4378.
36. Pham NL, Badovinac VP, Harty JT. 2009. A default pathway of memory CD8 T cell differentiation after dendritic cell immunization is deflected by encounter with inflammatory cytokines during antigen-driven proliferation. J. Immunol. 183:2337-2348.
37. Raghavan M, Del Cid N, Rizvi SM, Peters LR. 2008. MHC class I assembly: out and about. Trends Immunol. 29:436-44.
38. Raué HP, Slifka MK. 2009. CD8+ T cell immunodominance shifts during the early stages of acute LCMV infection independently from functional avidity maturation. Virology 390:197-204.
39. Raué HP, Slifka MK. 2007. Pivotal advance: CTLA-4+ T cells exhibit normal antiviral functions during acute viral infection. J. Leukoc. Biol. 81:1165-1175.
40. Rock KL, Shen L. 2005. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol. Rev. 207:166 -183.
41. Rodriguez F, Slifka MK, Harkins S, Whitton JL. 2001. Two overlapping subdominant epitopes identified by DNA immunization induce protective CD8(+) T-cell populations with differing cytolytic activities. J. Virol. 75:7399 -7409.
42. Seder RA, Darrah PA, Roederer M. 2008. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8:247-258.
43. Shen H, et al. 1995. Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc. Natl. Acad. Sci. U. S. A. 92:3987-3991.
44. Shin H, Wherry EJ. 2007. CD8 T cell dysfunction during chronic viral infection. Curr. Opin. Immunol. 19:408-415.
45. Sigal LJ, Rock KL. 2000. Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)- dependent and -independent pathways of antigen presentation. J. Exp. Med. 192:1143-1150.
46. Slifka MK, et al. 1996. Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes. J. Virol. 70:2902-2910.
47. Slifka MK, Whitton JL. 2000. Activated and memory CD8+T cells can be distinguished by their cytokine profiles and phenotypic markers. J. Immunol. 164:208 -216.
48. Speidel K, et al. 1997. Priming of cytotoxic T lymphocytes by five heataggregated antigens in vivo: conditions, efficiency, and relation to antibody responses. Eur. J. Immunol. 27:2391-2399.
49. Sun Y, Santra S, Schmitz JE, Roederer M, Letvin NL. 2008. Magnitude and quality of vaccine-elicited T-cell responses in the control of immunodeficiency virus replication in rhesus monkeys. J. Virol. 82:8812- 8819.
50. Takagi A, et al. 2009. Highly efficient antiviral CD8+ T-cell induction by peptides coupled to the surfaces of liposomes. Clin. Vaccine Immunol. 16:1383-1392.
51. Tebo AE, et al. 2005. Rapid recruitment of virus-specific CD8 T cells restructures immunodominance during protective secondary responses. J. Virol. 79:12703-12713.
52. Tewari K, Sacha J, Gao X, Suresh M. 2004. Effect of chronic viral infection on epitope selection, cytokine production, and surface phenotype of CD8 T cells and the role of IFN-gamma receptor in immune regulation. J. Immunol. 172:1491-1500.
53. van der Most RG, et al. 1998. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice. Virology 240:158 -167.
54. Walsh CM, et al. 1994. Immune function in mice lacking the perforin gene. Proc. Natl. Acad. Sci. U. S. A. 91:10854 -10858.
55. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77:4911- 4927.
56. Wherry EJ, et al. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4:225-234.
57. Whitmire JK, Eam B, Benning N, Whitton JL. 2007. Direct interferongamma signaling dramatically enhancesCD4+ and CD8+T cell memory. J. Immunol. 179:1190 -1197.
58. Whitmire JK, Tan JT, Whitton JL. 2005. Interferon-gamma acts directly on CD8+ T cells to increase their abundance during virus infection. J. Exp. Med. 201:1053-1059.
59. Whitton JL, Slifka MK, Liu F, Nussbaum AK, Whitmire JK. 2004. The regulation and maturation of antiviral immune responses. Adv. Virus Res. 63:181-238.
60. Yamamoto N. 1969. Damage, repair, and recombination. II. Effect of hydrogen peroxide on the bacteriophage genome. Virology 38:457- 463.
61. Yewdell JW, Bennink JR. 1999. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17:51- 88.
62. Yoshimura Y, et al. 2004. Duration of alloantigen presentation and avidity of T cell antigen recognition correlate with immunodominance of CTL response to minor histocompatibility antigens. J. Immunol. 172:6666-6674.
63. Yu TW, Anderson D. 1997. Reactive oxygen species-induced DNA damage and its modification: a chemical investigation. Mutat. Res. 379:201-210.
64. Zajac AJ, et al. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205-2213.